Results 181 to 190 of about 22,102,546 (289)

Plasma amylin levels in migraine and after erenumab treatment: A REFORM study

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Plain Language Summary Researchers are searching for blood tests that can show what is happening in migraine and help predict who will benefit from preventive treatment, and blood amylin (a signaling molecule known to trigger migraine) has been shown to be elevated in people with chronic migraine.
Rogelio Domínguez‐Moreno   +8 more
wiley   +1 more source

Neuropeptide Y-Graphene Oxide Complexes Inhibit Amygdala NPY-Receptor Expressing Glutamatergic Pathways and Selectively Remove Aversive Memory In Vivo. [PDF]

open access: yesAdv Sci (Weinh)
Pati E   +10 more
europepmc   +1 more source

Novel targets in headache: A narrative review

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background This narrative review summarizes novel applications for the use of calcitonin gene‐related peptide (CGRP)‐targeted therapies that go beyond migraine, the latest updates with respect to targeting pituitary adenylate cyclase‐activating peptide (PACAP) as therapeutic in migraine, as well as exploring other more recently ...
Adriana Della Pietra   +5 more
wiley   +1 more source

Loss of Neuropeptide Y Signaling Accompanies the Neural-to-Mesenchymal Transcriptional Transition in Glioblastoma: A Multi-Scale Transcriptomic Analysis. [PDF]

open access: yesInt J Mol Sci
Arshad F   +11 more
europepmc   +1 more source

Perceived headache responses to exercise in patients with migraine: A cross‐sectional study

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To characterize patient‐perceived headache responses to exercise in migraine and to identify associated clinical factors using a large‐scale registry. Background Regular exercise is often recommended for patients with migraine; however, it can also trigger migraine attacks.
Young‐Eun Gil, Mi Ji Lee
wiley   +1 more source

Orofacial pain disorder or trigeminal autonomic cephalalgia? Insights into pathophysiology and implications in medicine and dentistry

open access: yesHeadache: The Journal of Head and Face Pain, EarlyView.
There are some headache disorders known as trigeminal autonomic cephalalgias (TACs). When these “headaches” are localized in the mid‐face region, they are known as “trigeminal autonomic orofacial pains” (TAOPs), and they can mimic other types of face pains including dental pain, which puts the patient at risk of receiving treatments that are incorrect.
Marcela Romero‐Reyes, Simon Akerman
wiley   +1 more source

Neuropeptide Y

open access: yesBritish Journal of Pharmacology, 2009
openaire   +2 more sources

The Association of Neuropeptide Y with the Presence and Frequency of Ventricular Premature Beats. [PDF]

open access: yesCurr Cardiol Rev
Dedeoglu NF   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy